Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Susceptibility of teratocarcinoma cells to adenovirus type 2

Abstract

As mouse embryos develop they become susceptible to infection by the small DNA oncogenic viruses, simian virus 40 and polyoma1,2. Recently, the mouse teratocarcinoma, an alternative model system for the study of early development3,4, was used in an approach to understanding how differentiation affects host–virus interaction (ref. 5 and M.B. and F.K., unpublished). Several differential teratocarcinoma lines were shown to be fully permissive to polyoma virus and could be transformed by SV40, therefore reacting to viral infection like most commonly used mouse cells. In contrast, the multipotential embryonal carcinoma cells were resistant to both viruses and the block seems to lie early in the lytic cycle, after penetration of the virus, but before synthesis of the viral T antigen. Adenoviruses have much in common with the papovaviruses but are larger and more complex. We therefore examined the susceptibility of teratocarcinoma cells to these viruses. Here we report that both embryonal carcinoma cells and cells from a differentiated teratocarcinoma line are susceptible to adenovirus type 2.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Solter, D., Biczysko, W., and Koprowski, H., in Viruses, Evolution and Cancer (edit. by Kurstak, E., and Maramorosch, K.), 3–30 (Academic, New York, 1974).

    Google Scholar 

  2. Dawe, C. J., in Tissue Interaction in Carcinogenesis (edit. by Tarin, D.), 305–358 (Academic, New York, 1972).

    Google Scholar 

  3. Jacob, F., in The Early Development of Mammals (edit. by Balls and Wild), 233–241 (Cambridge University Press, Cambridge, 1975).

    Google Scholar 

  4. Gail, R. M., Cell, 5, 229–243 (1975).

    Article  Google Scholar 

  5. Swartzendruber, D. E., and Lehman, J. M., J. cell. Physiol., 85, 179–187 (1975).

    Article  CAS  Google Scholar 

  6. Stevens, L. C., Devl Biol., 21, 364–382 (1970).

    Article  CAS  Google Scholar 

  7. Jakob, H., Boon, T., Gaillard, J., Nicolas, J. F., and Jacob, F., Ann. Microbiol. (Inst. Pasteur), 124 B, 269–282 (1973).

    CAS  Google Scholar 

  8. Nicolas, J. F., Dubois, P., Jakob, H., Gaillard, J., and Jacob, F., Ann. Microbiol. (Inst. Pasteur), 126 A, 3–22 (1975).

    CAS  Google Scholar 

  9. Philipson, L., Virology, 15, 263–268 (1961).

    Article  CAS  Google Scholar 

  10. Tooze, J., in The Molecular Biology of Tumor Virus (edit. by Cold Spring Harbor Laboratory), 420–469 (Cold Spring Harbor, New York, 1973).

    Google Scholar 

  11. Ginsberg, H. S., Ensinger, M. J., Kauffman, R. S., Mayer, A. J., and Lundholm, U., Cold Spring Harb. Symp. quant. Biol., 39, 419–426 (1974).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

KELLY, F., BOCCARA, M. Susceptibility of teratocarcinoma cells to adenovirus type 2. Nature 262, 409–411 (1976). https://doi.org/10.1038/262409a0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/262409a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing